GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000320511 | Prostate | Tumor | cardiac chamber development | 43/3246 | 161/18723 | 1.86e-03 | 1.09e-02 | 43 |
GO:004298711 | Prostate | Tumor | amyloid precursor protein catabolic process | 22/3246 | 68/18723 | 1.87e-03 | 1.10e-02 | 22 |
GO:004866014 | Prostate | Tumor | regulation of smooth muscle cell proliferation | 47/3246 | 180/18723 | 1.95e-03 | 1.13e-02 | 47 |
GO:009873211 | Prostate | Tumor | macromolecule deacylation | 33/3246 | 116/18723 | 2.00e-03 | 1.16e-02 | 33 |
GO:190241412 | Prostate | Tumor | protein localization to cell junction | 28/3246 | 94/18723 | 2.03e-03 | 1.16e-02 | 28 |
GO:003300211 | Prostate | Tumor | muscle cell proliferation | 61/3246 | 248/18723 | 2.26e-03 | 1.28e-02 | 61 |
GO:00515461 | Prostate | Tumor | keratinocyte migration | 9/3246 | 19/18723 | 2.42e-03 | 1.36e-02 | 9 |
GO:00342051 | Prostate | Tumor | amyloid-beta formation | 19/3246 | 57/18723 | 2.54e-03 | 1.41e-02 | 19 |
GO:003433213 | Prostate | Tumor | adherens junction organization | 17/3246 | 49/18723 | 2.61e-03 | 1.43e-02 | 17 |
GO:000300711 | Prostate | Tumor | heart morphogenesis | 60/3246 | 246/18723 | 2.99e-03 | 1.61e-02 | 60 |
GO:009907212 | Prostate | Tumor | regulation of postsynaptic membrane neurotransmitter receptor levels | 20/3246 | 62/18723 | 3.07e-03 | 1.63e-02 | 20 |
GO:004865914 | Prostate | Tumor | smooth muscle cell proliferation | 47/3246 | 184/18723 | 3.12e-03 | 1.64e-02 | 47 |
GO:00148121 | Prostate | Tumor | muscle cell migration | 31/3246 | 110/18723 | 3.15e-03 | 1.65e-02 | 31 |
GO:003052012 | Prostate | Tumor | intracellular estrogen receptor signaling pathway | 18/3246 | 54/18723 | 3.26e-03 | 1.70e-02 | 18 |
GO:190353211 | Prostate | Tumor | positive regulation of secretion by cell | 67/3246 | 282/18723 | 3.53e-03 | 1.82e-02 | 67 |
GO:004693112 | Prostate | Tumor | pore complex assembly | 9/3246 | 20/18723 | 3.73e-03 | 1.91e-02 | 9 |
GO:000223716 | Prostate | Tumor | response to molecule of bacterial origin | 83/3246 | 363/18723 | 3.95e-03 | 2.00e-02 | 83 |
GO:000721912 | Prostate | Tumor | Notch signaling pathway | 44/3246 | 172/18723 | 4.02e-03 | 2.04e-02 | 44 |
GO:000320611 | Prostate | Tumor | cardiac chamber morphogenesis | 33/3246 | 121/18723 | 4.16e-03 | 2.09e-02 | 33 |
GO:00487382 | Prostate | Tumor | cardiac muscle tissue development | 57/3246 | 236/18723 | 4.67e-03 | 2.29e-02 | 57 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ADA | SNV | Missense_Mutation | | c.217N>A | p.Ala73Thr | p.A73T | P00813 | protein_coding | deleterious(0.01) | benign(0.386) | TCGA-A2-A0CM-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | PD |
ADA | SNV | Missense_Mutation | rs748974674 | c.935N>G | p.Lys312Arg | p.K312R | P00813 | protein_coding | tolerated(0.15) | benign(0.007) | TCGA-A8-A08O-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | PD |
ADA | SNV | Missense_Mutation | rs121908721 | c.872N>T | p.Ser291Leu | p.S291L | P00813 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-C8-A1HE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ADA | insertion | Frame_Shift_Ins | novel | c.1006_1007insTGGGTACTACAAGTTG | p.Pro336LeufsTer9 | p.P336Lfs*9 | P00813 | protein_coding | | | TCGA-A7-A0D9-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | SD |
ADA | insertion | Frame_Shift_Ins | novel | c.946_947insT | p.Gly316ValfsTer4 | p.G316Vfs*4 | P00813 | protein_coding | | | TCGA-A8-A06P-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unspecific | | SD |
ADA | insertion | Nonsense_Mutation | novel | c.944_945insCCCAGGCTGAATAAGTCCATTCCTGCACGTGTCTGCGA | p.Met315IlefsTer4 | p.M315Ifs*4 | P00813 | protein_coding | | | TCGA-A8-A06P-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unspecific | | SD |
ADA | SNV | Missense_Mutation | | c.347C>T | p.Pro116Leu | p.P116L | P00813 | protein_coding | deleterious(0.01) | possibly_damaging(0.614) | TCGA-EX-A69L-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ADA | SNV | Missense_Mutation | novel | c.340N>A | p.Pro114Thr | p.P114T | P00813 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-ZJ-AAX4-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD |
ADA | SNV | Missense_Mutation | | c.824N>G | p.Asp275Gly | p.D275G | P00813 | protein_coding | tolerated(0.15) | benign(0.045) | TCGA-AA-3663-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ADA | SNV | Missense_Mutation | | c.754N>A | p.Leu252Met | p.L252M | P00813 | protein_coding | deleterious(0.05) | probably_damaging(0.987) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | 2,3-DIDEOXYADENOSINE | | 3496090 |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | PENTOSTATIN | PENTOSTATIN | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | DIPYRIDAMOLE | DIPYRIDAMOLE | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | inhibitor | 178101507 | PENTOSTATIN | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | 6-METHYLMERCAPTOPURINE RIBOSIDE | | 10102 |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy | | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | HYDROCORTISONE | HYDROCORTISONE | 2395837 |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | Pentostatin | PENTOSTATIN | |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | CORDYCEPIN | CORDYCEPIN | 24283924 |
100 | ADA | DRUGGABLE GENOME, ENZYME, EXTERNAL SIDE OF PLASMA MEMBRANE, CELL SURFACE | | COBALT | | 9144774 |